We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.53%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.36B
AUM Growth
+$77.6M
Cap. Flow
+$46.1M
Cap. Flow %
3.39%
Top 10 Hldgs %
13.88%
Holding
1,633
New
514
Increased
325
Reduced
386
Closed
373

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$14.2M
2
DOMO icon
Domo
DOMO
+$12.7M
3
NFLX icon
Netflix
NFLX
+$12.4M
4
EA
Electronic Arts
EA
+$12.3M
5
DAY
Dayforce
DAY
+$11.5M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$17.1M
2
COOP
Mr. Cooper
COOP
+$13.5M
3
K
Kellanova
K
+$11.9M
4
LITE icon
Lumentum
LITE
+$9.69M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$9.44M

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Healthcare 13.54%
3 Communication Services 10.55%
4 Consumer Discretionary 9.61%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STNE icon
1126
StoneCo
STNE
$2.52B
$148K 0.01%
+10,017
New +$168K
TWI icon
1127
Titan International
TWI
$457M
$148K 0.01%
+18,900
New +$148K
ASC icon
1128
Ardmore Shipping
ASC
$670M
$148K 0.01%
13,944
-14,610
-51% -$174K
LAW icon
1129
CS Disco
LAW
$271M
$148K 0.01%
19,012
+612
+3% +$4.32K
THRY icon
1130
Thryv Holdings
THRY
$95.5M
$147K 0.01%
+24,289
New +$192K
EGY icon
1131
Vaalco Energy
EGY
$622M
$147K 0.01%
40,291
-16,179
-29% -$59.9K
VCIC
1132
DELISTED
Vine Hill Capital Investment Corp
VCIC
$145K 0.01%
13,500
-6,062
-31% -$66.4K
CRBP icon
1133
Corbus Pharmaceuticals
CRBP
$177M
$145K 0.01%
17,781
-49,203
-73% -$607K
RTAC
1134
Renatus Tactical Acquisition Corp I
RTAC
$326M
$144K 0.01%
13,500
-6,062
-31% -$66.1K
CEPO
1135
Cantor Equity Partners I
CEPO
$272M
$141K 0.01%
13,500
-11,447
-46% -$120K
BRSP
1136
BrightSpire Capital
BRSP
$620M
$140K 0.01%
+25,000
New +$138K
SWIM icon
1137
Latham Group
SWIM
$860M
$139K 0.01%
+21,860
New +$153K
WULF icon
1138
TeraWulf
WULF
$8.08B
$138K 0.01%
12,017
-187,983
-94% -$2.52M
TACO
1139
Berto Acquisition Corp
TACO
$392M
$137K 0.01%
13,500
-13,715
-50% -$141K
OPRX icon
1140
OptimizeRx
OPRX
$129M
$136K 0.01%
+11,063
New +$181K
NKTX icon
1141
Nkarta
NKTX
$176M
$136K 0.01%
73,300
+30,000
+69% +$60K
OIS icon
1142
Oil States International
OIS
$534M
$135K 0.01%
+19,901
New +$128K
VNDA icon
1143
Vanda Pharmaceuticals
VNDA
$304M
$133K 0.01%
+15,100
New +$83.1K
AQST icon
1144
Aquestive Therapeutics
AQST
$538M
$133K 0.01%
20,569
-17,904
-47% -$112K
EHAB
1145
DELISTED
Enhabit
EHAB
$132K 0.01%
14,355
-1,700
-11% -$14.7K
RGP icon
1146
Resources Connection
RGP
$145M
$128K 0.01%
25,463
-11,512
-31% -$54.9K
HUN icon
1147
Huntsman Corp
HUN
$1.82B
$128K 0.01%
12,833
-7,988
-38% -$73.1K
BVS icon
1148
Bioventus
BVS
$1.17B
$128K 0.01%
17,150
+6,160
+56% +$44.3K
UBFO
1149
DELISTED
United Security Bancshares
UBFO
$125K 0.01%
+12,434
New +$119K
SEVN
1150
Seven Hills Realty Trust
SEVN
$170M
$125K 0.01%
+14,000
New +$131K
44 45
46
47 48

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Prelude Capital Management held 1,633 positions worth $1.36B, up 6.1% from $1.28B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management deployed $46.1M of net new capital in Q4 2025, opening 514 new positions and adding to 325 existing holdings. Its largest new stake was Nice: 117,600 shares worth $13.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lumentum, an estimated $9.69M trimmed.

  • Prelude Capital Management's largest Q4 2025 buy was Nice: 117,600 shares worth $13.3M.
  • Prelude Capital Management added most to Domo in Q4 2025, an estimated $12.7M increase.
  • Prelude Capital Management's biggest Q4 2025 reduction was Lumentum, cutting an estimated $9.69M.
  • Prelude Capital Management fully exited Verona Pharma in Q4 2025, selling an estimated $17.1M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.36B portfolio in Q4 2025.
  • Prelude Capital Management opened 514 new positions and closed 373 in Q4 2025.
  • Prelude Capital Management's portfolio value rose 6.1% quarter-over-quarter to $1.36B.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.